Acarbose Hypoglycemia: Why You Must Use Glucose, Not Sucrose
Acarbose blocks sucrose breakdown, so it won't raise low blood sugar. Treat acarbose-related hypoglycemia with glucose tablets or milk instead.
20 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 20 of 20 clinical reviews.
Acarbose blocks sucrose breakdown, so it won't raise low blood sugar. Treat acarbose-related hypoglycemia with glucose tablets or milk instead.
Treatment layers RAS blockade, an SGLT2 inhibitor, and finerenone or a GLP-1 drug for persistent albuminuria, started early before fibrosis sets in.
A comprehensive clinical guide to diabetic retinopathy covering how chronic hyperglycemia damages retinal vessels, the four ETDRS stages, screening intervals, laser and anti-VEGF treatments, and the HbA1c targets that cut progression risk.
A clinical comparison of berberine vs. metformin: shared mechanism, what trial evidence actually shows, A1C and glucose targets, dangerous thresholds, and the dawn phenomenon, with an evidence-boundary map.
Farxiga lowers blood sugar via the kidneys, cuts heart failure hospitalization by 27%, and slows kidney disease. Starting dose is 5 mg daily, up to 10 mg.
Evidence-based glipizide guide covering immediate- and extended-release dosing, hypoglycemia, kidney considerations, and accurate comparisons with common diabetes medicines.
GLP-1 drugs can trigger low blood sugar 2-4 hours after eating by amplifying insulin release. Learn causes, symptoms, the MMTT test, and treatment options.
Learn what the insulin correction factor (sensitivity factor) is, how to calculate it using the 1700 and 1800 rules, how it fits into basal-bolus therapy, and how clinicians adjust it over time.
Older adults face 2-3x higher hypoglycemia risk on insulin. See safe HbA1c targets, dosing adjustments for kidney function, and how to avoid overcorrection.
Januvia is weight-neutral with low hypoglycemia risk but modest HbA1c drop; Actos lowers glucose more but can cause weight gain and fluid retention.
A guide to metformin-associated lactic acidosis (MALA): real incidence rates, who is at risk, FDA contraindications, drug interactions, and when to hold or stop the drug safely.
Lantus and Basaglar share the same insulin glargine sequence and 100 U/mL strength but differ in price and pen device; Toujeo is 300 U/mL. Compare dosing here.
Learn how to titrate metformin safely, manage GI side effects, and understand how it fits into basal-bolus insulin regimens, carb counting, and insulin-to-carb ratio calculations.
A comparison of metformin and GLP-1 receptor agonists covering mechanism, efficacy, weight loss, cardiovascular outcomes, side effects, cost, and when to use each drug or both together.
Complete clinical guide to pioglitazone (Actos) for type 2 diabetes: mechanism, dosing, side effects, cardiovascular data, and head-to-head comparisons with metformin, glipizide, empagliflozin, and dapagliflozin.
Prandin (repaglinide) lowers HbA1c by 1.5-2.0 points with less hypoglycemia risk than glipizide. See dosing, mechanism, and how it compares to other diabetes drugs.
Prediabetes means fasting glucose 100-125 mg/dL or A1c 5.7-6.4%. Lifestyle changes cut type 2 diabetes risk by 58%, better than metformin alone.
NPH insulin peaks in 4 to 12 hours and lasts up to 24, while regular insulin acts faster and clears sooner. See dosing and OTC options like Humulin N.
SGLT2 inhibitors lower HbA1c by about 0.5 to 0.8 points, similar to DPP-4 inhibitors, but add proven heart and kidney protection guidelines now favor.
Tradjenta (DPP-4 inhibitor) lowers HbA1c 0.6-0.8% with no kidney dose changes needed; Jardiance works differently. Compare mechanism, dosing, and effects.